Effect of Ginsenoside Rg1 on Immune Efficacy of P30 Fusion Protein of Toxoplasma Gondii in Mice

王素华,蔡渭明,曲道峰,杜爱芳

DOI: https://doi.org/10.16656/j.issn.1673-4696.2010.03.009

2010-01-01

Abstract:One hundred and twenty ICR mice were randomly divided into 6 groups,each 20.With the exception of the normal saline group and the P30 fusion protein group as well as the P30 fusion protein-Freund's adjuvant group,the three Rg1 groups were immunized with P30 fusion protein+ginsenoside Rg1 at doses of 10,50 and 100μg/kg,respectively.Mice in the P30 fusion protein group were immunized with given fusion protein,and mice in the P30 fusion protein-Freund's adjuvant group were immunized with fusion protein with different adjuvant by subcutaneous injection at different sites,while mice in the normal saline group was injected with PBS.Two weeks later,the ICR mice in all the groups were boostered at the same dose and in the same way,respectively.The results showed that ginsenoside Rg1 could significantly increase the level of lymphocyte proliferation and the body's immune response.The P30 fusion protein-Freund's adjuvant group showed the strongest protective efficacy.Of the three Rg1 groups,the P30 fusion protein+ginsenoside Rg1 group at the dose of 50μg/kg showed the strongest adjuvant effects.